Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Averto Medical is a medical device manufacturing company.
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Tioga Cardiovascular is a healthcare company providing valve replacement solutions for mitral and tricuspid applications.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
AccurEdit develops safe, targeted in vivo gene editing and delivery tech for severe hereditary and acquired diseases.
BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3Kα malignancies.
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Cormorant Asset Management has invested in 209 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cormorant Asset Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 17 different industry categories.
Among tracked funding rounds, Avidity Biosciences received $690.0M in a Post Ipo Equity round. Cormorant Asset Management's total known invested capital is $23.5B.
Cormorant Asset Management's average investment size is $137.2M across its portfolio of 209 companies.
Recent Cormorant Asset Management portfolio additions include Freenome, Centessa Pharmaceuticals, MoonLake Immunotherapeutics, X4 Pharmaceuticals, Tango Therapeutics. These companies were founded in 2020 or later.